Healthcare Triangle Inc. (HCTI) carries a Roarable Rating of E (Strong Sell) with 15/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-02, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 15/100 at a spot price of $5.14 (-18.41% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #713 in composite RQD confidence.
Within the Technology sector (EDP Services), HCTI carries a Roarable E (15/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).
Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 33.6 (NEUTRAL RANGE)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 8890.6% Gross Margin
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
While HCTI currently carries a cautious 15/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($12.46) and Max Pain ($5.40) forces dealer call-delta covering toward $3,559.50.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Healthcare Triangle Inc. (HCTI) dropped -18.41% to $5.14, trading at 2% of its 52-week range ($5.14 – $3390). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced the launch of Neurotechnology AI Devices Sales and Soluti
Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced that its wholly owned, AI-led subsidiary, Purpose Health, Inc., has signed a series of multi-year agreements. Purpose Health has signed a
A multi-year MSA for EHR optimization and healthcare cybersecurity, MEDITECH-based Rural Health Transformation advisory work in three states, in addition to a new multi-year engagement to support a healthcare business
Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences indus
Healthcare Triangle, Inc. (Nasdaq: HCTI) ("Healthcare Triangle," "HCTI" or the "Company") today highlighted developments across its AI-enabled customer engagement and healthcare technology operations, including six signe
Healthcare Triangle, Inc. (Nasdaq: HCTI) ("Healthcare Triangle," "HCTI" or the "Company") today highlighted developments across its AI-enabled customer engagement and healthcare technology
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HCTI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HCTI. Explore sector supply chains on /butterfly.
Across 714 tracked Technology securities in the Roarable RQD universe, Healthcare Triangle Inc. (HCTI) ranks #713 by composite RQD confidence (15/100, grade E) and #671 by equity capitalization ($5.6M). Within this direct 5-issuer industry benchmark cohort, HCTI leads on earnings valuation at N/A trailing P/E, while VS leads on capital efficiency and profitability with -17.7% ROIC and 96.0% gross margin. ARBB currently holds the highest overall quantitative score in the immediate peer group at 47/100 (D) compared with HCTI at 15/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| HCTI
ACTIVE
Healthcare Triangle Inc. | E | 15/100 | — | 96.0% | -35.0% | -18.41% | $5.6M | Benchmark Subject |
| CYN Cyngn Inc. | E | 24/100 | — | 38.0% | -35.0% | -5.49% | $5.6M | /cyn-vs-hcti → |
| VS Versus Systems Inc. | E | 32/100 | — | 96.0% | -17.7% | -3.21% | $5.3M | /vs-vs-hcti → |
| ARBB ARB IOT Group Limited | D | 47/100 | — | — | — | +6.00% | $6.2M | /arbb-vs-hcti → |
| AUUD Auddia Inc. | E | 33/100 | — | — | -35.0% | -5.23% | $4.9M | /auud-vs-hcti → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Healthcare Triangle Inc. (HCTI) reported GAAP revenue of $13.9M (+18.8% vs. FY2024 revenue of $11.7M , and -58.2% cumulative change since FY2023) , GAAP net income of -$9.5M, operating cash flow of -$16.5M, and free cash flow of -$16.5M (-1429.0% YoY). On the balance sheet, HCTI closed FY2025 with $22.7M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $13.9M | -$9.5M | -$16.5M | -$16.5M | $22.7M | — |
| FY2024 (FY) | 2024-12-31 | $11.7M | -$6.0M | -$1.1M | -$1.1M | $2.0M | — |
| FY2023 (FY) | 2023-12-31 | $33.2M | -$8.7M | -$2.2M | -$2.2M | — | — |
As of 2026-11-02, Healthcare Triangle Inc. (NASDAQ: HCTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 15/100 at a spot price of $5.14 (-18.41% 1D, market cap $5.6M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, HCTI ranks #713 in composite RQD confidence.
Within the Technology sector (EDP Services), HCTI carries a Roarable E (15/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, CYN (Cyngn Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $5.6M) and VS (Versus Systems Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -17.7%, cap $5.3M). Among the 5-stock peer group, HCTI leads on earnings multiple (N/A) while VS leads on capital efficiency (-17.7% ROIC).
Per HCTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839285), Healthcare Triangle Inc. generated $13.9M in revenue (+18.8% YoY), -$9.5M in net income, and -$16.5M in free cash flow against $22.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
HCTI last traded at $5.14 (-18.41% on volume of 12,343 shares), positioning the stock -58.75% below its 50-day simple moving average ($12.46) and -92.16% below its 200-day simple moving average ($65.60). Across its 52-week range of $5.14 to $3,390.00, HCTI sits at the 0.0% percentile with a 14-day RSI of 33.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.50 to $5.78).
Why HCTI Stock dropped -18.41% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).